What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
New type of non-opioid pain medication approved by FDA
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...
Doctors say people who take common medication should avoid 'toxic' fruit
Between seven and eight million adults in the UK are thought to take the tablet every day and eating one fruit could cause issues ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert ...
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Vertex Pharmaceuticals’ non-opioid Journavx approved for pain by FDA
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
Shop’s licence revoked after 680,000 illegal cigarettes and Viagra tablets seized
A Peterborough shop’s licence has been revoked after large amounts of illegal products were seized. Officers carried out a ...
Guinea has wiped out sleeping sickness – will the rest of Africa follow?
Sleeping sickness is no longer a health threat in Guinea, which may be a tipping point in the continent’s efforts to beat the ...
Zawya3 天
Hera Health Solutions wins Arab Health’s Innov8 competition, securing $10,000 top prize
An international lineup of the world’s leading healthcare start-ups competed in the final of the Innov8 competition ...